SCHEMBL6964299

SCHEMBL6964299

CCc1[nH]c2ccccc2c1C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.57
TDP1 Q9NUW8 1/20 0.57
OXER1 Q8TDS5 1/20 0.52
ALDH1A1 P00352 5/20 0.49
KMT2A Q03164 3/20 0.47
MITF O75030 1/20 0.47
LMNA P02545 1/20 0.47
RAB9A P51151 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
PLA2G2A P14555 1/20 0.46
MAPT P10636 4/20 0.46
GAA P10253 3/20 0.46
HSD17B10 Q99714 2/20 0.46
MEN1 O00255 1/20 0.46
HPGD P15428 1/20 0.46
GFER P55789 1/20 0.46
PKM P14618 1/20 0.46
APP P05067 1/20 0.45
CASP1 P29466 1/20 0.45
CASP7 P55210 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30602834 1.00 KDM4E (0.57) KDM4ETDP1OXER1ALDH1A1KMT2A
SCHEMBL9840962 0.89 KDM4E (0.53) KDM4ETDP1OXER1ALDH1A1KMT2A
SCHEMBL7551694 0.87 OXER1 (0.60) KDM4ETDP1OXER1ALDH1A1KMT2A
SCHEMBL1538815 0.87 ALDH1A1 (0.50) KDM4ETDP1OXER1ALDH1A1KMT2A
SCHEMBL26963262 0.86 KDM4E (0.55) KDM4ETDP1OXER1ALDH1A1KMT2A
SCHEMBL6014774 0.86 KDM4E (0.61) KDM4ETDP1OXER1ALDH1A1KMT2A
SCHEMBL8782766 0.85 OXER1 (0.66) KDM4ETDP1OXER1ALDH1A1MAPT
SCHEMBL7070059 0.84 OXER1 (0.72) KDM4ETDP1OXER1ALDH1A1MAPT
SCHEMBL15175477 0.82 NR4A2 (0.65) KDM4EALDH1A1KMT2ALMNAGAA
SCHEMBL5510275 0.81 KDM4E (0.56) KDM4ETDP1OXER1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117756785-A Preparation and application of N- (pyridine-2-yl) benzo [ b ] five-membered heterocycle-3-carboxamide structure compound 江西中医药大学 2024-03-26 CN disclosed
CN-110041119-A A kind of poly- remittance agent of soil carbon dioxide 河南丰汇农业技术有限公司 2019-07-23 CN disclosed
CN-110041119-A A kind of poly- remittance agent of soil carbon dioxide 河南丰汇农业技术有限公司 2019-07-23 CN disclosed
EP-0891331-B1 N-(2 OXOACETYL OR SULPHONYL)-PYRROLIDINE/PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY VERTEX PHARMA (US) 2003-10-01 EP disclosed
US-5935954-A TREATING THE PATIENT SUFFERING FROM PARKINSON'S DISEASE, ALZHIMER'S DISEASE, STROKE AND ISCHEMIA ASSOCIATED WITH STROKE, NEURAL PAROPATHY, SCIATIC CRUSH, SPINAL CORD INJURY OR FACIAL NERVE CRASH VERTEX PHARMACEUTICALS INCORPORATED (US) 1999-08-10 US disclosed
EP-0891331-A1 N-(2 OXOACETYL OR SULPHONYL)-PYRROLIDINE/PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY Vertex Pharmaceuticals Incorporated (US) 1999-01-20 EP disclosed
US-5717092-A Compounds with improved multi-drug resistance activity VERTEX PHARMACEUTICALS INC. (US) 1998-02-10 US disclosed
WO-1997036869-A1 N-(2 OXOACETYL OR SULPHONYL)-PYRROLIDINE/PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY VERTEX PHARMACEUTICALS INCORPORATED (US) 1997-10-09 WO disclosed